Akcea Therapeutics, Inc.

Carlsbad, CA, United States

1

Total Recalls

1

Class I Recalls

0

Ongoing Recalls

Recalls by Akcea Therapeutics, Inc.

FDA Drug Class I Terminated

Tegsedi (inotersen) Injection 284 mg/1.5 mL, Rx Only, Sterile solution for Subcutaneous Use, 4 prefilled syringes, each containing 284 mg of inotersen, (equivalent to 300 mg inotersen sodium in 1.5 ml

May 23, 2022 Akcea Therapeutics, Inc. 450 cartons units